LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SNS-032 | 1.11 | uM | LJP6 | 3 | H15 | 72 | hr | 1694 | 294 | 11121 | 0.0264 | -0.4754 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 1 | H14 | 72 | hr | 1694 | 323 | 11220 | 0.0288 | -0.4554 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 2 | H14 | 72 | hr | 1694 | 287 | 11309 | 0.0254 | -0.4771 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 3 | H14 | 72 | hr | 1694 | 314 | 11121 | 0.0282 | -0.4626 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 1694 | 350 | 11220 | 0.0312 | -0.4391 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 1694 | 326 | 11309 | 0.0288 | -0.4522 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 1694 | 422 | 11121 | 0.0379 | -0.4007 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 1694 | 1526 | 11220 | 0.1360 | -0.0376 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 1694 | 1790 | 11309 | 0.1583 | 0.0203 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 1694 | 1864 | 11121 | 0.1676 | 0.0358 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 1694 | 1502 | 11220 | 0.1339 | -0.0432 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 1694 | 1730 | 11309 | 0.1530 | 0.0077 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 1694 | 1735 | 11121 | 0.1560 | 0.0088 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 1694 | 1474 | 11220 | 0.1314 | -0.0498 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 1694 | 1667 | 11309 | 0.1474 | -0.0059 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 1694 | 1968 | 11121 | 0.1770 | 0.0567 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 1694 | 1468 | 11220 | 0.1308 | -0.0512 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1694 | 1785 | 11309 | 0.1578 | 0.0192 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1694 | 2115 | 11121 | 0.1902 | 0.0851 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 1694 | 1863 | 11220 | 0.1660 | 0.0354 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 1694 | 1765 | 11309 | 0.1561 | 0.0150 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 1694 | 1977 | 11121 | 0.1778 | 0.0585 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 1694 | 1818 | 11220 | 0.1620 | 0.0262 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 1694 | 1586 | 11309 | 0.1402 | -0.0238 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 1694 | 1888 | 11121 | 0.1698 | 0.0407 |